Lazard Asset Management
PLX icon

Lazard Asset Management’s Protalix BioTherapeutics PLX Stock Holding History

Lazard Asset Management’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-797
Closed -$2K – 2479
2025
Q1 		$2K Sell
797
-458
-36% -$1.15K ﹤0.01% 2209
2024
Q4 		$2K Buy
+1,255
New +$2K ﹤0.01% 2188